Multilayered particles are emerging as a powerful platform in pharmaceutics, especially for targeted, triggered and sustained drug delivery. These novel delivery systems exhibit advantages over single-layered particles, such as mitigating burst release of drugs. In this article, an overview of recent developments in the fabrication of multilayered polymeric particles, towards their utilization in therapeutic applications, will be provided. Fabrication techniques that aid in engineering multilayered particles will first be discussed.Towards the end, a critical outlook on the key issues associated with this particulate delivery system will be addressed.Scheme 1 Schematic diagram of the build-up of multilayer assemblies on spherical particles by consecutive adsorption of anionic and cationic polyelectrolytes. This diagram is highly idealized. In reality, the layers are well interpenetrated. Adapted from webpage: http://www.pharmafocusa sia.com/researchdevelopment/layer-by-layer-micro-nano-drugencapsulation-eolyelectrolytes.html. Fig. 1 (PVPON/TA)n multilayers were formed on spherical SiO 2 cores using H-bonded LbL assembly (1). After core dissolution, spherical capsules, with the shell diameter of D and the shell thickness of t, were drop-cast on Si wafers and dried at room temperature to result in hemispherical concave particles with the opening size of S (2). 31Scheme 5 Schematic illustration of the encapsulation of water-insoluble therapeutics in PMA SH nanocapsules via mesoporous silica templating. (I) Loading of water-insoluble therapeutics into MS particles; (II) LbL assembly of a multilayer polymer shell on the surface of the drug-loaded MS particles; (III) removal of the MS particle, leading to polymer capsule encapsulated therapeutics. 98